Apimeds shares surge 12.21% intraday after closing $100M PIPE and activating 1,000 Bitcoin for AI yield.

Apimeds Pharmaceuticals surged 12.2% intraday following the announcement of its $100 million PIPE financing and the activation of 1,000 Bitcoin to support AI-driven yield generation. The financing, which strengthens the company’s financial position, accelerates its non-opioid therapeutic programs and integrates MindWave Innovations’ digital asset framework. The strategic move to leverage Bitcoin for programmatic returns and align corporate operations was highlighted as a pivotal development by executives, signaling enhanced growth prospects and operational resilience. This news directly aligns with the sharp intraday rally, reflecting investor optimism over the capital infusion and expanded business model. Other events, such as board resignations, were either unrelated or disclosed post-price movement.